| Case | Karyotype | ABL deletions | RT-PCR | BCR-ABL/ABL (%) diagnosis | BCR-ABL/ABL (%) after imatinib |
| (a) | 46, XY, t(5;9;22)(q31;q34;q11)/45, X, idem, Y/46, X, idem, +8/46, XY, +8, t(5;9;22)/46, XY, 4, t(5;9;22), 7, +der(X)? t(X;1)(p11.4;q21), +mar | NO | b3a2 | 11.09 | 0.11 | (b) | 46, XX, t(9;22;10)(q34;q11;q22) | NO | b3a2 | 1.75 | 0.014 | (c) | 46, XX, t(7;9;22)(q34;q11;q32) | NO | b3a2 | 13.56 | 0.004 | (d) | 45, XY, t(3;9;22)(q21;q34;q11), 15/46, XY, idem, +22/46, XY | NO | b3a2 | 11.06 | Negative | (e) | 46, XX, t(8;9;22)(q24.1;q34;q11) | NO | b3a2 | N.A | Negative |
|
|